Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
スポンサーリンク
概要
- 論文の詳細を見る
- 1997-12-30
著者
-
YAMORI Takao
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yamori Takao
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer
-
SATO Shigeo
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re
-
Kadota Toshihito
Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K. K
-
CHIKAZAWA Hirotaka
Kanagawa Laboratories, Bristol-Myers Squibb K.K.,
-
Chikazawa Hirotaka
Kanagawa Laboratories Clinical Research & Product Development Division Bristol-myers Squibb K.k.
-
Sato Shigeo
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
Yamori Takao
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
CHIKAZAWA Hirotaka
Kanagawa Laboratories, Clinical Research & Product Development Division, Bristol-Myers Squibb K. K.
関連論文
- Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library
- YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis : I. Fermentation, Isolation and Biological Activities
- Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 : III. In Vitro and In Vivo Antitumor Activities
- Isolation of a Novel Gene Showing Reduced Expression in Metastatic Colorectal Carcinoma Cell Lines and Carcinomas
- Absolute Quantification of Four Isoforms of the Class I Phosphoinositide-3-kinase Catalytic Subunit by Real-Time RT-PCR(Communications to the Editor)
- Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines
- Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
- Identification of JTP-70902, a p15^-inductive compound, as a novel MEK1/2 inhibitor
- ANTITUMOR EFFICACIES OF ACLACINOMYCIN A BY ORAL ADMINISTRATION
- Establishment of a Hepatocyte Cell Line Producing Growth-promoting Factors for Liver-colonizing Tumor Cells
- Anticancer and Some Biological Activities of Thiazinotrienomycin B
- Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells(Highlighted paper selected by Editor-in-chief,Miscellaneous)
- Sesquiterpenoids and Flavonoids from the Aerial Parts of Tithonia diversifolia and Their Cytotoxic Activity
- Rectal Absorption of [Bis (acetato) ammine dichloro (cyclohexylamine)platinum(IV)](BMS-182751), a New Anti-tumor Agent, in Rats
- β-Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
- Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria
- Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
- Phosphatidylinositol 3-kinase inhibitors : promising drug candidates for cancer therapy
- Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase(Pharmacology)
- Schedule-dependent and -independent Antitumor Activity of Paclitaxel-based Combination Chemotherapy against M-109 Murine Lung Carcinoma in vivo
- Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo
- ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms
- Potentiation of Bleomycin in Jurkat Cells by Fungal Pycnidione
- Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors
- Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines